We read with great interest the study entitled "Pigment epithelium-derived factor affects angiogenesis in celiac disease" by Akpinar et al. [1] . In this study, which was the first of this type in the literature, the authors reported high levels of pigment epitheliumderived factor (PEDF) in patients with celiac disease, an inflammatory process. PEDF is a protein that belongs to the serpin protease inhibitor family having multifunctional effects such as antiangiogenic, anti-inflammatory, and neuroprotective properties [1] . Due to these features, PEDF has been considered important in recent scientific studies.
Levels of PEDF were also investigated in patients with hepatic steatosis. Yılmaz et al. [2] demonstrated that serum levels of PEDF were significantly increased in patients with biopsy-proven nonalcoholic fatty liver disease and were associated with hepatic steatosis independently of traditional risk factors. Nonalcoholic fatty liver disease has become a major public health problem worldwide, and its spectrum extends from isolated steatosis involving mild fatty infiltration to active injury in association with inflammation (nonalcoholic steatohepatitis), cirrhosis, and even hepatocellular carcinoma [3] .
Previous studies revealed that fatty liver disease is more common in patients with celiac disease, and that celiac disease is more
